Biocon Biologics Gets EU Approval for Bone Health Drugs

Imagine your bones are like the walls of a building, and sometimes they get weak.

Biocon Biologics has made copies of a medicine that helps make bones stronger.

These medicines, called Vevzuo and Evfraxy, are now approved in Europe.

Vevzuo is for people whose bones are affected by cancer or have rare tumors.

Evfraxy is for people with weak bones called osteoporosis, or those losing bone because of other treatments.

These medicines work just like the original ones and have been proven safe.

Biocon is excited to bring these medicines to more people to help them stay healthy.